| abstract |
The present invention relates to compounds of formula (I), pharmaceutically acceptable salts thereof or solvates thereof. The present invention also relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier and an effective amount of a compound of formula (I). In addition, the present invention provides a method for treating allergy (eg, asthma), inflammation, hypotension and elevated intraocular pressure (eg, glaucoma), i.e. elevated intraocular pressure, sleep disorders, excessive exercise in the gastrointestinal tract, and low exercise and excessive gastric acid. And administering an effective amount of a compound of Formula I to a patient in need of treatment for a lack of Methods of treating allergies (eg, asthma), inflammation, hypotension and elevated intraocular pressure (eg, glaucoma), including administering, ie elevated intraocular pressure, sleep disorders, overexertion of the gastrointestinal tract and low motor status and gastric acid. It relates to methods for treating excess and lack of gastric acid, hyperactivity and deactivation of the central nervous system (eg anxiety and anxiety) and other CNS diseases (eg Alzheimer's syndrome, schizophrenia, obesity and migraine). The present invention also describes a method of treating an upper airway allergic reaction, including administering a compound of formula (I), a salt thereof, or a solvate thereof in combination with a histamine H 1 receptor antagonist.n n n Formula I |